We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

These Immune Players Deserve More Time in the Limelight

News   Sep 21, 2018 | By Heather Buschman, PhD for UC San Diego Health

 
Cancer Immunotherapy Might Benefit From Previously Overlooked Immune Players

Major Histocompatibility Complex (MHC) molecules display antigens to T cells, immune cells that constantly check for infected or damaged cells. If T cells spot MHC molecules with foreign antigens or mutated self-antigens (such as cancer antigens), they kill the cell before the damage spreads. MHC-II is only displayed by professional immune cells, such as macrophages, and is recognized by CD4+ T cells. MHC-I is displayed on the surface of every cell, and thus any cell with the potential to become cancerous, and is recognized by CD8+ T cells. Credit: UC San Diego Health

 
 
 

RELATED ARTICLES

Dual Anthrax-Plague Vaccine Effective in Multiple Animal Models

News

A dual vaccine against the causative agents of anthrax and the plague is effective in three animal models.

READ MORE

Retina Restoration Could Return Vision to Our Canine Friends

News

A stem cell-based approach is being developed to treat blindness in dogs.

READ MORE

Immune Culprits Linked to Inflammation and Bone Loss in Gum Disease

News

Microbes in the mouth trigger specialized immune cells that inflame and destroy tissues, leading to bone loss associated with severe gum disease.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE